Versión de HTML Básico
49
Antonio Jiménez Pacheco
Probióticos e infecciones urinarias recurrentes
21:347-54.
4. Waigankar SS, Patel V. Role of probiotics in urogenital healthcare. J
Midlife Health. 2011; 2 5-10.
5. Reid G, Dols J, Miller W. Targeting the vaginal microbiota with pro-
biotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care.
2009; 12:583-7.
6. Abad CL, Safdar N. The role of lactobacillus probiotics in the
treatment or prevention of urogenital infections—a systematic review. J
Chemother. 2009; 21:243-52.
7. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial
genitourinary infections in women: a review. Clin Ther. 2008; 30:453-68.
8. Martín R, Soberón N, Vázquez F, Suárez JE. Vaginal microbiota:
composition, protective role, associated pathologies, and therapeutic pers-
pectives. Enferm Infecc Microbiol Clin. 2008; 26:160-7.
9. Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid
I, et al. Prevention and treatment of urinary tract infection with probiotics:
Review and research perspective. Indian J Urol. 2008; 24:139-44.
10. Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for preven-
tion of recurrent urinary tract infections in women: a review of the evidence
from microbiological and clinical studies. Drugs. 2006; 66:1253-61.
11. Reid G, Bruce AW. Probiotics to prevent urinary tract infections:
the rationale and evidence. World J Urol. 2006; 24:28-32.
12. Reid G, Burton J, Devillard E. The rationale for probiotics in female
urogenital healthcare. MedGenMed. 2004; 6:49.
13. Reid G, Bruce AW. Urogenital infections in women: can probiotics
help? Postgrad Med J. 2003; 79:428-32.
14. Bruce AW, Reid G. Bruce AW, Reid G. Probiotics and the urologist.
Can J Urol. 2003; 10:1785-9.
15. Miller JL, Krieger JN. Urinary tract infections cranberry juice,
underwear, and probiotics in the 21st century. Urol Clin North Am. 2002;
29:695-9.
16. Reid G. Probiotics for urogenital health. Nutr Clin Care. 2002; 5:3-8.
17. Reid G. The role of cranberry and probiotics in intestinal and uro-
genital tract health. Crit Rev Food Sci Nutr. 2002; 42:293-300.
18. Reid G, Burton J. Use of Lactobacillus to prevent infection by
pathogenic bacteria. Microbes Infect. 2002; 4:319-24.
19. Reid G, Bruce AW. Could probiotics be an option for treating and
preventing urogenital infections?. Medscape Womens Health. 2001; 6:9.
20. Hooton TM. Recurrent urinary tract infection in women. Int J An-
timicrob Agents. 2001; 17:259-68.
21. Elmer GW. Probiotics: “living drugs”. Am J Health Syst Pharm.
2001; 58:1101-9.
22. Reid G. Probiotic agents to protect the urogenital tract against
infection. Am J Clin Nutr. 2001; 73:437S-443S.
23. Reid G. Probiotic Therapy and Functional Foods for Prevention of
Urinary Tract Infections: State of the Art and Science. Curr Infect Dis Rep.
2000; 2:518-522.
24. Barbés C, Boris S. Potential role of lactobacilli as prophylactic
agents against genital pathogens. AIDS Patient Care STDS. 1999; 13:747-51.
25. Reid G. Potential preventive strategies and therapies in urinary
tract infection. World J Urol. 1999; 17:359-63.
26. Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there
a role for lactobacilli in prevention of urogenital and intestinal infections?
Clin Microbiol Rev. 1990; 3:335-44.
27. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA,
de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infec-
tions: a randomized, double-blind, noninferiority trial in postmenopausal
women. Arch Intern Med. 2012; 172:704-12.
28. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari
M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG
drink for the prevention of urinary tract infections in women. BMJ. 2001;
322:1571.
29. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL,
Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lacto-
bacillus crispatus probiotic given intravaginally for prevention of recurrent
urinary tract infection. Clin Infect Dis. 2011; 52:1212-7.
30. Baerheim A, Larsen E, Digranes A. Vaginal application of lactoba-
cilli in the prophylaxis of recurrent lower urinary tract infection in women.
Scand J Prim Health Care. 1994; 12:239-43.
31. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and sti-
mulation of indigenous organisms to prevent recurrence of urinary tract
infections. Microecol Ther. 1995; 23: 32–45.
32. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial
therapy and lactobacillus vaginal suppositories on recurrence of urinary
tract infections. Clin Ther. 1992; 14:11-6.
33. Kontiokari T, Laitinen J, Järvi L, Pokka T, Sundqvist K, Uhari M. Die-
tary factors protecting women from urinary tract infection. Am J Clin Nutr.
2003; 77:600-4.
34. Juárez Tomás MS, Saralegui Duhart CI, De Gregorio PR, Vera Pingi-
tore E, Nader-Macías ME. Urogenital pathogen inhibition and compatibility
between vaginal Lactobacillus strains to be considered as probiotic candi-
dates. Eur J Obstet Gynecol Reprod Biol. 2011; 159:399-406.
35. McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, et al.
Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfa-
ces. 2011; 86:58-64.
36. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A
pilot study evaluating the safety and effectiveness of Lactobacillus vaginal
suppositories in patients with recurrent urinary tract infection. Int J Antimi-
crob Agents. 2006; 28 Suppl 1:S30-4
37. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by
orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003;
5(11):767-9.
38. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B.
Oral probiotics can resolve urogenital infections. FEMS Immunol Med Mi-
crobiol. 2001; 30:49-52.
39. Foxman B, Barlow R; D´Arcy H, Gillespie B, Sobel JD. Urinary tract
infection: self-reported incidence and associated cost. Ann Epidemiol 2000;
10: 509-15.
40. Parkes GC. An overview of probiotics and prebiotics. Nurs Stand.
2007; 21:43-7.
41. Coppens P, Fernandes da Silva M, Pettman S. European regula-
tions on nutroceuticals, dietary supplements and functional foods: A frame-
work based on safety. Toxicology 2006; 221: 59-74.
42. Hoesl CE, Altwein JE. The Probiotic Approach: An Alternative
Treatment Option in Urology. Eur Urol 2005; 47: 288-96.
43. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital
probiotic applications. J Infect Dis 2011; 183: 77-80.
44. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-prod-
ucts inhibit the growth and virulence of uropathogenic Escherichia coli. J
Physiol Pharmacol. 2009; 60 Suppl 6:13-8.